$PGEN Cashflow Statement | Understand Stock

$PGEN

$6.23 +$0.08 (1.3%) After hours

$PGEN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Gain (Loss) on disposals of assets, net
Impairment of goodwill
Impairment of other noncurrent assets
Gain on sale of discontinued operations
Gain on debt retirement
Unrealized and realized depreciation on equity securities and preferred stock, net
Noncash dividend income
Loss on reclassification of cumulative foreign currency translation adjustments
Loss on settlement agreement
Change in fair value of warrant liabilities
Amortization of discounts on investments, net
Equity in net income of affiliates
Stock-based compensation expense
Shares issued as payment for services
Provision for credit losses
Accretion of debt discount and amortization of deferred financing costs
Total deferred tax (benefit)
Noncash gain on termination of leases
Issuance cost related to Warrants
Other noncash items
Changes in operating assets and liabilities:
Receivables:
Trade
Related parties
Other

Inventory
Prepaid expenses and other
Other assets
Accounts payable
Accrued compensation and benefits
Other accrued liabilities
Deferred revenue
Lease liabilities
Related party payables
Other long-term liabilities
Indemnification Accruals

Net cash used in operating activities
Cash flows from investing activities
Purchases of investments
Sales and maturities of investments
Proceeds from sales of equity securities
Investments in affiliates
Decrease in cash from deconsolidation of subsidiary
Return of investment in affiliate
Purchases of property, plant and equipment
Proceeds from sale of assets
Proceeds from repayment of notes receivable
Net cash used in investing activities

Cash flows from financing activities
Advances from lines of credit
Repayments of advances from lines of credit
(Payments) Proceeds from issuance of common stock, net of issuance costs
Proceeds from long-term debt, net of issuance costs
Payments of long-term debt, including cost to retire of $120 in 2023
Payments of cost to retire long-term debt
Payment of stock issuance costs
(Payments) Proceeds from issuance of Series A Preferred Stock and Warrants, net of issuance cost
Cash Settlement of Performance Stock Units
Payments to taxing authorities in connection with shares directly withheld from employees
Proceeds from stock option exercises
Net cash provided by financing activities

Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash
Beginning of year
End of year
Supplemental disclosure of cash flow information
Cash paid during the period for interest
Cash paid during the period for income taxes
Significant noncash activities
Fair value of stock received as consideration for collaboration agreements
Fair value of stock issued upon conversion of long-term debt
Fair value of stock issued in conjunction with settlement agreement
Accrued compensation paid in equity awards
Conversion of preferred stock to common stock
Settlement of warrants to equity
Purchases of property and equipment included in accounts payable and other accrued liabilities
Proceeds from sale of assets included in receivables
Issuance costs included in accounts payable and other accrued liabilities

Comments